https://www.selleckchem.com/products/trolox.html
In Model 3, the incidence was higher only among participants aged 50-64 years and severe disabled participants aged less then 50 years. CV mortality was significantly higher in participants with disability than in those without disability in all Models, and the mortality increased in both sexes in Models 1 and 2 but only increased in men in Model 3. Similar results were observed in the subgroup analysis of health behavior and chronic diseases. People with disability showed higher CV disease incidence and mortality than those without disa
Like
Comment
Share
